Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Axitinib
Related studies linked through entity extraction aliases.
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Axitinib as Maintenance Treatment in Patients With Metastatic CRC
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Axitinib in Advanced Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nasopharyngeal Carcinoma (NPC) Axitinib
- Status
- COMPLETED
- Phase
- PHASE2
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
- Status
- COMPLETED
- Phase
- NA
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2